Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 Remission frequency and use of antidepressant frequency at 3 and 6 months follow-up in the PRIM-CARE RCT. Remission defined as MADRS-S ≤ 12

From: Clinical effectiveness of care managers in collaborative care for patients with depression in Swedish primary health care: a pragmatic cluster randomized controlled trial

  3 months Intervention
N = 149
3 months Control
N = 152
p 6 months Intervention
N = 146
6 months Control
N = 152
p
n (%) n (%)   n (%) n (%)  
Remission according to MADRS-S (≤ 12) 74 (49.7) 73 (42.4) 0.20 98 (67) 72 (47) 0.001
Use of antidepressants 77 (50.7) 116(67.4) 0.02 75 (51.0) 92(60.5) 0.10
Individuals (n; %) on sick leave 83 (54.6) 88 (51.2) 0.54 59 (40.1) 64 (42.1) 0.73
Individuals (n;%) with return to work (full or part-time) 40(62.5) 33(42.9) 0.02 7 (33) 10 (33) 1.0
  1. Italic figures; statistically significant difference between intervention and control group